An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...
Morning Overview on MSN
ARPA-H is building clinical AI agents designed for FDA authorization and trials
The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, published a new program on January 13, 2026, with an ambitious target: building the ...
14d
Does Positive Phase 3 BBP-418 Data in LGMD2I/R9 Change The Bull Case For BridgeBio Pharma (BBIO)?
BridgeBio Pharma, Inc. recently announced that interim Phase 3 FORTIFY trial data for BBP-418 in limb-girdle muscular dystrophy type 2I/R9 met efficacy endpoints, with expanded results to be presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results